Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Anticancer Research
|
July 1, 1987
The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomas
E Teske, C M Besselink, M A Blankenstein, et al.
Cancer Letters
|
October 25, 2001
Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas
L Nasir, G R Rutteman, S W Reid, et al.
Cancer Research
|
June 15, 1988
Flow cytometric analysis of DNA ploidy in canine mammary tumors
G R Rutteman, C J Cornelisse, N J Dijkshoorn, et al.
Endocrinology
|
January 1, 1994
Progestin-induced growth hormone excess in the dog originates in the mammary gland
P J Selman, J A Mol, G R Rutteman, et al.
Anticancer Research
|
June 6, 1998
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a randomized clinical trial in dogs with mammary carcinoma
E Teske, G R Rutteman, T S vd Ingh, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 3, 2001
Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland
I S Lantinga-van Leeuwen, E van Garderen, G R Rutteman, et al.
The Veterinary Record
|
May 9, 2006
Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining
A J F Matos, A M R Faustino, C Lopes, et al.
Cytogenetics and Cell Genetics
|
October 9, 1998
Analysis of chromosome aberrations in a mammary carcinoma cell line from a dog by using canine painting probes
O T Tap, G R Rutteman, C Zijlstra, et al.
Journal of Comparative Pathology
|
March 21, 2006
E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables
A J F Matos, C Lopes, J Carvalheira, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 20, 2003
Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry
A Zacchetti, E van Garderen, E Teske, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Anticancer Research
|
July 1, 1987
The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomas
E Teske, C M Besselink, M A Blankenstein, et al.
Cancer Letters
|
October 25, 2001
Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas
L Nasir, G R Rutteman, S W Reid, et al.
Cancer Research
|
June 15, 1988
Flow cytometric analysis of DNA ploidy in canine mammary tumors
G R Rutteman, C J Cornelisse, N J Dijkshoorn, et al.
Endocrinology
|
January 1, 1994
Progestin-induced growth hormone excess in the dog originates in the mammary gland
P J Selman, J A Mol, G R Rutteman, et al.
Anticancer Research
|
June 6, 1998
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a randomized clinical trial in dogs with mammary carcinoma
E Teske, G R Rutteman, T S vd Ingh, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 3, 2001
Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland
I S Lantinga-van Leeuwen, E van Garderen, G R Rutteman, et al.
The Veterinary Record
|
May 9, 2006
Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining
A J F Matos, A M R Faustino, C Lopes, et al.
Cytogenetics and Cell Genetics
|
October 9, 1998
Analysis of chromosome aberrations in a mammary carcinoma cell line from a dog by using canine painting probes
O T Tap, G R Rutteman, C Zijlstra, et al.
Journal of Comparative Pathology
|
March 21, 2006
E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables
A J F Matos, C Lopes, J Carvalheira, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 20, 2003
Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry
A Zacchetti, E van Garderen, E Teske, et al.
Page
of 9